|
⚲
|
| Keyboard |
| The Baupost Group LLC
✚
|
|
|---|---|
| CRD # | 109530 |
| SEC # | 801-55245 |
| CIK # | 0001061768 |
| AUM | 24.68 B (2026-03-30) |
| Employees | 210 (21% Investors, 0% Brokers) |
| Phone | 617-210-8300 |
| Address | 10 St James Ave Suite 1700 Boston, MA 02116 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($B) |
|---|
| In the News | |
|---|---|
| Wed, 01 Apr 2026 | Newmark Arranges $525 Million Refinancing for The Artise on Behalf of Schnitzer West and The Baupost Group — PR Newswire |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Wesco International Inc | 0.4 | ||
| Union Pacific Corp | 0.4 | ||
| Wellpoint Inc | 0.4 | ||
| Alphabet Inc | 0.3 | ||
| Ferguson Enterprises Inc /DE/ | 0.3 | ||
| Willis Group Holdings PLC | 0.3 | ||
| Aon Corp | 0.2 | ||
| Visa Inc | 0.2 | ||
| Teleflex Inc | 0.2 | ||
| Eagle Materials Inc | 0.2 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | BG Co-Investment 2024 LLC | [2025-02-21] | 221.7 M | 77.6 M |
| Offered $221,681,414 · Filed 2025-03-27 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Net Assets Decline to Disclose | ||||
| HF | Baupost Limited Partnership 1983 A-1 | 2012-03-30 | 3,065.8 M | |
| HF | Baupost Limited Partnership 1983 B-1 | 2012-03-30 | 1,288.5 M | |
| HF | Baupost Limited Partnership 1983 C-1 | 2012-03-30 | 7,097.0 M | |
| HF | Baupost Limited Partnership 1987 F-1 | 2012-03-30 | 0.1 M | |
| HF | Baupost Value Partners LP - I | 2012-03-30 | 1,416.0 M | |
| HF | Baupost Value Partners LP - II | 2012-03-30 | 2,301.5 M | |
| HF | Baupost Value Partners LP - III | 2012-03-30 | 896.7 M | |
| HF | Baupost Value Partners LP - IV | [2012-03-30] | 11.13 B | 7,476.5 M |
| Filed 2025-03-24 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | BSP Partners LP | 2012-03-30 | 9.0 M | |
| View All | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 12 | 24.7 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 12 | 24.7 |
| By Discretionary | ||
| Discretionary | 12 | 24.7 |
| Non-Discretionary | 0 | 0.0 |
| Total | 12 | 24.7 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 24.7 | |
| Total | 12 | 24.7 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Robert Bralower | Executive Officer | 11 | 3 | |
| Michael Demichele | Executive Officer | 10 | 3 | |
| Brian Spector | Executive Officer | 13 | 2 | |
| Ryan Dow | Executive Officer | 12 | 2 | |
| George Rizk | Executive Officer | 12 | 2 | |
| Gregory Ciongoli | Executive Officer | 12 | 2 | |
| Thomas Blumenthal | Executive Officer | 11 | 2 | |
| James David | Executive Officer | 11 | 2 | |
| Jason Price | Executive Officer | 10 | 2 | |
| Seth Klarman | Executive Officer | 10 | 2 | |
| James Mooney III | Executive Officer | 10 | 2 | |
| Joshua Greenhill | Executive Officer | 10 | 2 | |
| Elaine Mann | Executive Officer | 10 | 2 | |
| Herbert Wagner III | Executive Officer | 9 | 2 | |
| Paul Gannon | Executive Officer | 9 | 2 | |
| Barbara O'Connor | Executive Officer | 9 | 2 | |
| Frederick Fogel | Executive Officer | 9 | 2 | |
| Scott Nathan | Executive Officer | 9 | 2 | |
| Samuel Plimpton | Executive Officer | 9 | 2 | |
| Richard Corona | Executive Officer | 8 | 2 | |
| Nicholas Azrack | Executive Officer | 8 | 2 | |
| Andy McElaney | Executive Officer | 8 | 2 | |
| Michael Sperling | Executive Officer | 8 | 2 | |
| Jianshu Dong | Executive Officer | 7 | 2 | |
| Mark Tsocanos | Executive Officer | 7 | 2 | |
| David Freibaum | Executive Officer | 7 | 2 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001061768] | |
| 3 | [0001061768] | |
| 4 | [0001061768] | |
| SC 13D | [0001061768] | |
| SC 13G | [0001061768] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $23.8B |
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 549300HN0XPLCFCUIL94 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Veritiv Corp VRTV
Common Stock
|
2023-11-30 | Other | 3,324,324 | $170.00 | 565,135,080 |
|
Garrett Motion Inc GTX
Common Stock
|
2023-06-15 | Sell | 1,025,000 | $7.55 | 7,738,750 |
|
Garrett Motion Inc GTX
Common Stock
|
2023-06-14 | Sell | 3,100,000 | $7.73 | 23,963,000 |
|
Garrett Motion Inc GTX
Series A Cumulative Convertible Preferred Stock · derivative
|
2023-06-13 | Conversion | 25,462,810 | ||
|
Garrett Motion Inc GTX
Common Stock
|
2023-06-13 | Conversion | 25,462,810 | ||
|
Garrett Motion Inc GTX
Common Stock
|
2023-06-13 | Sell | 500,000 | $8.00 | 4,000,000 |
|
Garrett Motion Inc GTX
Series A Preferred Stock · derivative
|
2023-06-08 | Sell | 17,482 | ||
|
Garrett Motion Inc GTX
Common Stock
|
2023-06-08 | Sell | 500,000 | $8.20 | 4,100,000 |
|
Garrett Motion Inc GTX
Series A Preferred Stock · derivative
|
2021-12-10 | Sell | 1,827,868 | $8.20 | 14,988,518 |
|
Garrett Motion Inc GTX
Series A Preferred Stock · derivative
|
2021-05-11 | Sell | 761,905 | ||
|
Garrett Motion Inc GTX
Series A Preferred Stock · derivative
|
2021-05-07 | Sell | 380,952 | ||
|
Garrett Motion Inc GTX
Common Stock
|
2021-04-30 | Other | 3,575,000 | ||
|
Viasat Inc VSAT
Common Stock
|
2020-07-23 | Buy | 2,556,891 | $39.11 | 100,000,007 |
|
Translate Bio Inc TBIO
Common Stock
|
2020-06-26 | Buy | 500,000 | $22.00 | 11,000,000 |
|
Orexigen Therapeutics Inc OREXQ
0% Senior Secured Convertible Notes due 2020 · derivative
|
2019-05-31 | Other | 5,000,000 | ||
|
Orexigen Therapeutics Inc OREXQ
Warrant Expiring 2020 · derivative
|
2019-05-31 | Other | 100,000,000 | ||
|
Orexigen Therapeutics Inc OREXQ
Warrant Expiring 2026 · derivative
|
2019-05-31 | Other | |||
|
Keryx Biopharmaceuticals Inc KERX
Common Stock
|
2018-12-12 | Disposed to issuer | 65,374,013 | ||
|
Keryx Biopharmaceuticals Inc KERX
Common Stock
|
2018-12-11 | Grant | 35,582,335 | $4.63 | 164,746,211 |
|
Keryx Biopharmaceuticals Inc KERX
Common Stock
|
2018-12-11 | Grant | 4,000,000 | ||
| showing 20 of 30 most recent transactions | |||||
| Related Firms | State | AUM |
|---|---|---|
|
The Baupost Group LLC
✚
|
MA | 24.68 B |
|
Baupost Group International LLP
✚
|
||
|
Baupost Group LLC/MA
✚
|
MA |
| Comparable Firms | State | AUM |
|---|---|---|
|
Alkeon Capital Management LLC
✚
|
NY | 25.29 B |
|
Pershing Square Capital Management LP
✚
|
NY | 25.06 B |
|
Fundsmith Investment Services Limited
✚
|
24.58 B | |
|
Arga Investment Management LP
✚
|
CT | 24.57 B |
|
Gabelli Funds LLC
✚
|
NY | 24.55 B |
|
Pictet Asset Management Limited
✚
|
24.40 B | |
|
Towers Watson Investment Management Limited
✚
|
24.32 B | |
|
Colchester Global Investors Ltd
✚
|
23.95 B | |
|
Systematica Investments Limited
✚
|
23.79 B | |
|
Moore Capital Management LP
✚
|
NY | 23.70 B |